Sign Up
Stories
Innovative Cardiac Support Devices Receive FDA Breakthrough Designation
Share
Cordis and Boston Scientific: Advancemen...
AI-Powered Raspberry Pi Stethoscope Inno...
Advanced Technology Saves Patient's Life
Attune Medical's Growth in Esophageal Te...
Overview
API
Three medical companies, Supira Medical, Magenta Medical, and PercAssist, have received FDA breakthrough device designation for their innovative cardiac support devices. Supira Medical's Supira System, Magenta Medical's Elevateā¢ Heart Pump, and PercAssist's PSCA System aim to disrupt the interventional cardiology market with their unique designs and clinical trials for high-risk PCI procedures and cardiogenic shock.
Ask a question
How might the development of these innovative cardiac support devices impact the interventional cardiology market and patient outcomes?
How might the success of these breakthrough devices influence the investment landscape in the cardiac support industry?
What challenges and ethical considerations might arise from the use of these percutaneous ventricular assist devices?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Coverage
stree